241 related articles for article (PubMed ID: 34058065)
41. Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy.
Yuwen D; Ma Y; Wang D; Gao J; Li X; Xue W; Fan M; Xu Q; Shen Y; Shu Y
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):163-173. PubMed ID: 30228154
[TBL] [Abstract][Full Text] [Related]
42. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
[TBL] [Abstract][Full Text] [Related]
43. Breast cancer cell-derived exosomal miR-20a-5p promotes the proliferation and differentiation of osteoclasts by targeting SRCIN1.
Guo L; Zhu Y; Li L; Zhou S; Yin G; Yu G; Cui H
Cancer Med; 2019 Sep; 8(12):5687-5701. PubMed ID: 31385464
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
Zou X; Xia T; Li M; Wang T; Liu P; Zhou X; Huang Z; Zhu W
Cancer Biomark; 2021; 30(1):41-53. PubMed ID: 32894240
[TBL] [Abstract][Full Text] [Related]
45. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1.
Shang A; Wang X; Gu C; Liu W; Sun J; Zeng B; Chen C; Ji P; Wu J; Quan W; Yao Y; Wang W; Sun Z; Li D
Aging (Albany NY); 2020 May; 12(9):8352-8371. PubMed ID: 32364530
[TBL] [Abstract][Full Text] [Related]
46. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
47. Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-κB signaling pathway.
Wang B; Mao JH; Wang BY; Wang LX; Wen HY; Xu LJ; Fu JX; Yang H
Cancer Lett; 2020 Oct; 489():87-99. PubMed ID: 32531321
[TBL] [Abstract][Full Text] [Related]
48. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
[TBL] [Abstract][Full Text] [Related]
49. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
[TBL] [Abstract][Full Text] [Related]
50. In Situ Detection of Plasma Exosomal MicroRNA-1246 for Breast Cancer Diagnostics by a Au Nanoflare Probe.
Zhai LY; Li MX; Pan WL; Chen Y; Li MM; Pang JX; Zheng L; Chen JX; Duan WJ
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39478-39486. PubMed ID: 30350935
[TBL] [Abstract][Full Text] [Related]
51. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
[TBL] [Abstract][Full Text] [Related]
52. miR-125a-5p expression is associated with the age of breast cancer patients.
He H; Xu F; Huang W; Luo SY; Lin YT; Zhang GH; Du Q; Duan RH
Genet Mol Res; 2015 Dec; 14(4):17927-33. PubMed ID: 26782438
[TBL] [Abstract][Full Text] [Related]
53. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
[TBL] [Abstract][Full Text] [Related]
54. Association of miR-1247-5p expression with clinicopathological parameters and prognosis in breast cancer.
Zhang P; Fan C; Du J; Mo X; Zhao Q
Int J Exp Pathol; 2018 Aug; 99(4):199-205. PubMed ID: 30175411
[TBL] [Abstract][Full Text] [Related]
55. Detection of plasma exosomal miRNA-205 as a biomarker for early diagnosis and an adjuvant indicator of ovarian cancer staging.
Zhu Z; Chen Z; Wang M; Zhang M; Chen Y; Yang X; Zhou C; Liu Y; Hong L; Zhang L
J Ovarian Res; 2022 Feb; 15(1):27. PubMed ID: 35183243
[TBL] [Abstract][Full Text] [Related]
56. Correlation Between miR-497-5p Expression With Clinicopathological Characteristics and Prognosis in Patients With Breast Cancer.
Zhang Z; Zhou Y; Liang S
Appl Immunohistochem Mol Morphol; 2024 Apr; 32(4):200-205. PubMed ID: 38497335
[TBL] [Abstract][Full Text] [Related]
57. Exosome-mediated delivery of miR-204-5p inhibits tumor growth and chemoresistance.
Yao S; Yin Y; Jin G; Li D; Li M; Hu Y; Feng Y; Liu Y; Bian Z; Wang X; Mao Y; Zhang J; Wu Z; Huang Z
Cancer Med; 2020 Aug; 9(16):5989-5998. PubMed ID: 32618144
[TBL] [Abstract][Full Text] [Related]
58. Plasma-based microRNA signatures in early diagnosis of breast cancer.
Li X; Zou W; Wang Y; Liao Z; Li L; Zhai Y; Zhang L; Gu S; Zhao X
Mol Genet Genomic Med; 2020 May; 8(5):e1092. PubMed ID: 32124558
[TBL] [Abstract][Full Text] [Related]
59. Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis.
Qiao EQ; Yang HJ; Zhang XP
J Zhejiang Univ Sci B; 2020 Jun; 21(6):495-508. PubMed ID: 32478495
[TBL] [Abstract][Full Text] [Related]
60. Diagnosis of Hyperacute and Acute Ischaemic Stroke: The Potential Utility of Exosomal MicroRNA-21-5p and MicroRNA-30a-5p.
Wang W; Li DB; Li RY; Zhou X; Yu DJ; Lan XY; Li JP; Liu JL
Cerebrovasc Dis; 2018; 45(5-6):204-212. PubMed ID: 29627835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
